This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
With increasing pressure from regulatory bodies and rising media costs, pharma marketers are rediscovering the power of personalized communication. Importantly, consistency in tone and branding across all pharma communications boosts credibility. However, in 2025, the digital transformation continues to accelerate.
You may ask: Can an open protocol be HIPAA compliant? HIPAA does not specifically prohibit using and sharing open protocol-based software. Their patient journey typically requires engaging with discrete service providers, who are often using antiquated means of communication. The time to cross that bridge has passed.
In an industry as specialized as healthcare, personalized communication can make or break your relationship with HCPs and patients. Staying compliant with regulations like HIPAA and GDPR is non-negotiable. Here’s a quick look at a successful email campaign in pharma: Objective : Increase awareness about a new diabetes drug.
Regulatory-Friendly Communication : Unlike social media ads, emails offer controlled messaging that aligns with compliance regulations. Challenges in Pharma Email Marketing Pharma brands face unique barriers that other industries dont , such as: Strict compliance regulations (FDA, GDPR, HIPAA) that limit messaging.
Pharmacy Performance Metrics Medication Adherence: Non-adherence to three chronic disease categories — oral diabetes medications, statins for cholesterol, and hypertension medications — impacts a pharmacy’s adherence score. To comply, pharmacies need to coordinate with doctors to get statins prescribed to patients with diabetes.
For instance, a guide explaining how Jardiance works for diabetes can help patients make informed decisions. Engaging on Digital Platforms: Patients are increasingly turning to online communities for advice and support. Clearly communicating the benefits and risks of drugs like Keytruda establishes credibility and trust.
You might have someone's weight, height, what they have eaten this week, their resting heart rate,” says Katherine Pomfret, head of communications at Syrenis. At this year’s American Diabetes Association annual scientific session, clinical trial data was presented that analysed 199 diabetes patients for an average of four years.
For instance, targeting a diabetes drug like Jardiance involves identifying adults struggling with Type 2 diabetes and tailoring messages about improved glycemic control. Solution: Partner with legal and compliance teams to ensure all campaigns adhere to FDA and HIPAA guidelines.
Similarly, healthcare providers expect personalized, timely communications that complement their clinical priorities. It means using data responsibly to tailor content, recommend resources, and support adherenceall while complying with HIPAA and other healthcare regulations.
For example, targeting oncologists for a drug like Opdivo requires a unique approach compared to marketing a diabetes treatment. Automation: Email marketing and CRM tools streamline communication, saving time while maintaining personalization. Following GDPR and HIPAA guidelines safeguards both your company and your audience.
As noted in our previous communications, while the NHC would prefer a more traditional Notice and Comment rulemaking opportunity that would ensure the Agency directly responds to stakeholder feedback, we welcome this opportunity to express our reactions to CMS’ thinking on the negotiation program.
Chronic Disease Management Independent pharmacies can play a crucial role in managing chronic diseases such as diabetes, hypertension, and asthma. Pharmacy teams can communicate with their patients via HIPAA-complaint, secure messages thus reducing time on the phone and increasing efficiency within the pharmacy.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content